reported that S100A16 promotes epithelial to mesenchymal transition (EMT) through the Notch pathway in breast cancer [36], while EMT enhanced the invasion and metastasis of epithelial cells and was associated with resistance to chemotherapy in a variety of tumors [37, 38]. Here, S100A16 is linked to breast carcinoma.